Conformational Enantiomerization and Estrogen Receptor alpha Binding of Anti-Cancer Drug Tamoxifen and Its Derivatives
2011 (English)In: Journal of chemical information and modeling, ISSN 1549-9596, Vol. 51, no 2, 306-314 p.Article in journal (Refereed) Published
The anticancer drug tamoxifen (TAM) displays two chiral vinyl propeller structures, which interconvert so rapidly that the process is undetectable on the NMR time scale. In the present work, the enantiomerization processes were investigated with molecular modeling techniques. The threshold mechanisms probed at the different rings were shown to be identical, i.e., involving a synchronous three-ring flip, with a correlated rotation of the rings. In order to reveal the pharmacological profiles of the two chiral forms, we performed structural studies on the ligand binding domain of estrogen receptor alpha. (ER alpha LBD) and associated ligands. The enantiomers, with opposite torsional twist, were found to be discriminated by ER alpha. For TAM and its main metabolites, the effects of the stereoselectivity of ER alpha are overcome by the low energy cost for helical inversion between the two torsional enantiomers, estimated to be similar to 3 kcal/mol.
Place, publisher, year, edition, pages
2011. Vol. 51, no 2, 306-314 p.
IdentifiersURN: urn:nbn:se:kth:diva-105742DOI: 10.1021/ci100401tISI: 000287685700012OAI: oai:DiVA.org:kth-105742DiVA: diva2:571909
FunderSwedish Research Council
QC 201211262012-11-262012-11-262012-11-26Bibliographically approved